Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 32.42%226.3M | 24.83%204.1M | 51.01%-73.1M | -12.68%307.2M | -4.69%122M | -21.28%170.9M | 68.04%163.5M | -64.68%-149.2M | 15.04%351.8M | 13.78%128M |
| Net income from continuing operations | 79.59%252.5M | -17.83%116.1M | -12.05%123.3M | 23.87%578.7M | -48.45%156.6M | 318.66%140.6M | 49.52%141.3M | 5.26%140.2M | 310.54%467.2M | 34.90%303.8M |
| Operating gains losses | 43.77%-96.6M | -150.00%-22M | -125.44%-51.4M | -40.21%-212.7M | 96.09%-9.3M | -680.41%-171.8M | -126.59%-8.8M | 75.40%-22.8M | -134.50%-151.7M | -1,275.72%-238M |
| Securities amortization | 26.03%-5.4M | 23.38%-5.9M | 9.72%-6.5M | -57.61%-29M | -6.25%-6.8M | -46.00%-7.3M | -97.44%-7.7M | -132.26%-7.2M | -319.05%-18.4M | -276.47%-6.4M |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | -314.49%-152.5M | -90.17%2.9M | ---- | ---- | ---- |
| Derivatives unrealized gains and losses | ---27.8M | --27.8M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | 71.93%9.8M | 9.68%6.8M | 118.18%7.2M | 12.68%23.1M | 36.21%7.9M | 23.91%5.7M | 10.71%6.2M | -26.67%3.3M | -1.91%20.5M | 0.00%5.8M |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 102.87%1.9M | ---- |
| Change in working capital | -54.39%88.8M | 119.04%95.5M | 39.16%-93.7M | 147.16%65.5M | 49.73%-18.8M | 44.65%194.7M | 152.53%43.6M | -0.59%-154M | 16.83%-138.9M | 27.38%-37.4M |
| -Change in loss and loss adjustment expense reserves | -44.49%134.9M | 72.10%69.7M | 84.11%-18.8M | 230.51%109.5M | -63.34%-55.7M | 66.10%243M | 149.39%40.5M | -3.68%-118.3M | 8.00%-83.9M | 43.54%-34.1M |
| -Change in reinsurance recoverable on paid and unpaid losses | 27.72%-26.6M | 259.26%19.4M | -755.26%-24.9M | 37.55%-15.8M | 148.16%11.8M | -894.59%-36.8M | -57.81%5.4M | 138.38%3.8M | 62.07%-25.3M | -131.13%-24.5M |
| -Change in payables and accrued expense | 37.50%1.1M | 369.57%6.2M | -2.52%-36.6M | -70.67%-25.6M | 8.41%11.6M | 108.70%800K | -129.87%-2.3M | -47.52%-35.7M | -5,100.00%-15M | 22.99%10.7M |
| -Change in other current assets | -67.48%-20.6M | --200K | -252.63%-13.4M | 82.31%-2.6M | 28.57%13.5M | -1,125.00%-12.3M | --0 | 22.45%-3.8M | -56.38%-14.7M | -2.78%10.5M |
| Tax refund paid | -28.82%-29.5M | -15.59%-48.2M | 39.97%-84.1M | -472.63%-243.7M | -172.09%-39M | -219.27%-22.9M | -847.73%-41.7M | -3,902.86%-140.1M | 155.99%65.4M | 1,358.14%54.1M |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 32.42%226.3M | 24.83%204.1M | 51.01%-73.1M | -12.68%307.2M | -4.69%122M | -21.28%170.9M | 68.04%163.5M | -64.68%-149.2M | 15.04%351.8M | 13.78%128M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,298.31%-1.24B | -201.13%-186.1M | -279.55%-189.6M | 15.32%-298M | 18.58%-252.9M | -580.54%-88.9M | 54.53%-61.8M | 38.76%105.6M | 6.08%-351.9M | -10.77%-310.6M |
| Net intangibles purchase and sale | -47.96%-29M | -78.26%-20.5M | -1.66%-30.7M | 13.60%-75.6M | 17.82%-14.3M | 24.90%-19.6M | 26.75%-11.5M | -6.71%-30.2M | 3.63%-87.5M | 14.71%-17.4M |
| Net business purchase and sale | -54.73%-22.9M | -229.01%-86.2M | 33.90%-39M | 61.23%-158.7M | 71.60%-58.7M | -27.59%-14.8M | 85.67%-26.2M | -619.51%-59M | -69.13%-409.3M | 8.94%-206.7M |
| Net investment property transactions | --0 | --22.1M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | -2,066.00%-1.19B | -360.73%-113.8M | -161.99%-120.5M | -143.37%-65.7M | -107.59%-180.4M | -185.27%-55M | -140.03%-24.7M | 73.26%194.4M | 379.52%151.5M | -144.10%-86.9M |
| Net proceeds payment for loan | -80.00%100K | 1,950.00%12.3M | 50.00%600K | 130.30%2M | 25.00%500K | 106.02%500K | -33.33%600K | 0.00%400K | -153.66%-6.6M | -84.62%400K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,298.31%-1.24B | -201.13%-186.1M | -279.55%-189.6M | 15.32%-298M | 18.58%-252.9M | -580.54%-88.9M | 54.53%-61.8M | 38.76%105.6M | 6.08%-351.9M | -10.77%-310.6M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 933.61%902.8M | 377.19%288M | 23.47%76.8M | -86.56%-113.8M | 194.52%36.2M | -290.97%-108.3M | -346.21%-103.9M | 267.20%62.2M | -183.11%-61M | -4.08%-38.3M |
| Increase decrease in deposit | -40.60%-70.3M | -19.72%-60.1M | 0.70%100.9M | --110.1M | --110.1M | ---50M | ---50.2M | --100.2M | --0 | --0 |
| Net issuance payments of debt | --996.3M | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 7,620.00%75.2M | --0 |
| Net common stock issuance | --0 | 2,542.11%371.2M | 219.51%4.9M | -391.37%-68.3M | -280.00%-34.2M | ---14.8M | ---15.2M | 16.33%-4.1M | 74.07%-13.9M | 31.82%-9M |
| Cash dividends paid | -22.28%-22.5M | -22.28%-22.5M | -14.05%-21.1M | -16.61%-73.7M | -17.20%-18.4M | -15.72%-18.4M | -16.46%-18.4M | -17.09%-18.5M | 0.16%-63.2M | -9.79%-15.7M |
| Net other financing charges | 97.21%-700K | 97.01%-600K | 48.70%-7.9M | -38.58%-81.9M | -56.62%-21.3M | -112.71%-25.1M | -10.44%-20.1M | 0.65%-15.4M | -130.89%-59.1M | -63.86%-13.6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 933.61%902.8M | 377.19%288M | 23.47%76.8M | -86.56%-113.8M | 194.52%36.2M | -290.97%-108.3M | -346.21%-103.9M | 267.20%62.2M | -183.11%-61M | -4.08%-38.3M |
| Net cash flow | ||||||||||
| Beginning cash position | -0.20%457M | -67.18%151M | -23.69%336.9M | -12.16%441.5M | -34.84%431.6M | 0.75%457.9M | 2.04%460.1M | -12.16%441.5M | 0.90%502.6M | -6.35%662.4M |
| Current changes in cash | -333.46%-114M | 14,009.09%306M | -1,099.46%-185.9M | -71.19%-104.6M | 57.13%-94.7M | -112.65%-26.3M | -161.11%-2.2M | 135.98%18.6M | -1,457.78%-61.1M | -7.91%-220.9M |
| End cash Position | -20.53%343M | -0.20%457M | -67.18%151M | -23.69%336.9M | -23.69%336.9M | -34.84%431.6M | 0.75%457.9M | 2.04%460.1M | -12.16%441.5M | -12.16%441.5M |
| Free cash flow | 30.40%197.3M | 20.79%183.6M | 42.14%-103.8M | -12.37%231.6M | -2.62%107.7M | -20.79%151.3M | 86.27%152M | -50.88%-179.4M | 22.93%264.3M | 20.09%110.6M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.